The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis
- 30 November 1995
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 23 (5) , 532-537
- https://doi.org/10.1016/0168-8278(95)80058-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Nomenclature for factors of the HLA system, 1994Tissue Antigens, 1994
- Analysis of risk factors for the development of liver disease associated with cystic fibrosisThe Journal of Pediatrics, 1994
- HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British caucasoidsHuman Immunology, 1992
- Genotype Analysis for ΔF508, G551d and R553x Mutations in Children and Young Adults With Cystic Fibrosis With and Without Chronic Liver DiseaseHepatology, 1992
- Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factorsHepatology, 1991
- Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosisThe Journal of Pediatrics, 1990
- Liver Disease and Common-Bile-Duct Stenosis in Cystic FibrosisNew England Journal of Medicine, 1988
- Hepatobiliary Disease in Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 1982
- The management of portal hypertension in cystic fibrosisJournal of Pediatric Surgery, 1977
- Hepatic changes in young infants with cystic fibrosis: Possible relation to focal biliary cirrhosisThe Journal of Pediatrics, 1975